Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease

Aim. To reveal the statistically significant determinants of the coronary artery (CA) stenosis ≥70% in patients with chronic stable CA disease receiving drug therapy.Material and methods. The study included 68 patients (aged 59.6±6.4 years) with stable CA disease and optimal cardioactive therapy. Co...

Full description

Saved in:
Bibliographic Details
Main Authors: O. A. Koshelskaya, T. E. Suslova, I. V. Kologrivova, N. Y. Margolis, O. A. Zhuravleva, O. A. Kharitonova, I. V. Vinnitskaya
Format: Article
Language:English
Published: Столичная издательская компания 2020-03-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/2108
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227639214047232
author O. A. Koshelskaya
T. E. Suslova
I. V. Kologrivova
N. Y. Margolis
O. A. Zhuravleva
O. A. Kharitonova
I. V. Vinnitskaya
author_facet O. A. Koshelskaya
T. E. Suslova
I. V. Kologrivova
N. Y. Margolis
O. A. Zhuravleva
O. A. Kharitonova
I. V. Vinnitskaya
author_sort O. A. Koshelskaya
collection DOAJ
description Aim. To reveal the statistically significant determinants of the coronary artery (CA) stenosis ≥70% in patients with chronic stable CA disease receiving drug therapy.Material and methods. The study included 68 patients (aged 59.6±6.4 years) with stable CA disease and optimal cardioactive therapy. Coronary angiography was performed in all patients. Basic serum parameters of carbohydrate and lipid metabolism were evaluated; serum concentration of cytokines, adipokines and high sensitive C-reactive protein (hsCRP) were determined by ELISA. The epicardial adipose tissue (EAT) thickness was measured by B-mode echocardiography.Results. The patients’ classification model was created. It allowed to determine probability P for CA stenosis of 70% or more for each patient using formula Р, where L=0.89-1.09×gender+ 0.51×triglycerides–0.28×HDL+0.24×hsCRP (HDL – high density lipoproteins). If calculated P value falls into interval (0; 0.228) the patient should be classified into the group with the risk of CA stenosis ≥70%, while if calculated P value falls into interval (0.228; 1), the patient should be classified into group with CA stenosis below 70%. Even though EAT thickness was indistinguishable determinant of CA stenosis ≥70% in our study, its inclusion into the model as a fifth variable allowed to increase the model quality: area under ROC-curve (AUC) in the model without EAT thickness constituted 0.708 (p=0.009), and increased up to 0.879 (p=0.011) after EAT thickness inclusion.Conclusions. Male sex, level of triglycerides, HDL and hsCRP are statistically significant determinants of CA stenosis ≥70%. The presence of the triglycerides level in the created model underscores an important contribution of this lipid fraction, even when elevated only up to the moderate values, into modulation of the residual cardiovascular risk in patients receiving statins.
format Article
id doaj-art-36b2f02d8ad14f819b5767d39cc22d4d
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2020-03-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-36b2f02d8ad14f819b5767d39cc22d4d2025-08-23T10:00:31ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532020-03-011614910.20996/1819-6446-2020-01-011693Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery DiseaseO. A. Koshelskaya0T. E. Suslova1I. V. Kologrivova2N. Y. Margolis3O. A. Zhuravleva4O. A. Kharitonova5I. V. Vinnitskaya6Tomsk National Research Medical Center, Russian Academy of Science, Cardiology Research InstituteTomsk National Research Medical Center, Russian Academy of Science, Cardiology Research InstituteTomsk National Research Medical Center, Russian Academy of Science, Cardiology Research InstituteTomsk State UniversityTomsk National Research Medical Center, Russian Academy of Science, Cardiology Research InstituteTomsk National Research Medical Center, Russian Academy of Science, Cardiology Research InstituteTomsk National Research Medical Center, Russian Academy of Science, Cardiology Research InstituteAim. To reveal the statistically significant determinants of the coronary artery (CA) stenosis ≥70% in patients with chronic stable CA disease receiving drug therapy.Material and methods. The study included 68 patients (aged 59.6±6.4 years) with stable CA disease and optimal cardioactive therapy. Coronary angiography was performed in all patients. Basic serum parameters of carbohydrate and lipid metabolism were evaluated; serum concentration of cytokines, adipokines and high sensitive C-reactive protein (hsCRP) were determined by ELISA. The epicardial adipose tissue (EAT) thickness was measured by B-mode echocardiography.Results. The patients’ classification model was created. It allowed to determine probability P for CA stenosis of 70% or more for each patient using formula Р, where L=0.89-1.09×gender+ 0.51×triglycerides–0.28×HDL+0.24×hsCRP (HDL – high density lipoproteins). If calculated P value falls into interval (0; 0.228) the patient should be classified into the group with the risk of CA stenosis ≥70%, while if calculated P value falls into interval (0.228; 1), the patient should be classified into group with CA stenosis below 70%. Even though EAT thickness was indistinguishable determinant of CA stenosis ≥70% in our study, its inclusion into the model as a fifth variable allowed to increase the model quality: area under ROC-curve (AUC) in the model without EAT thickness constituted 0.708 (p=0.009), and increased up to 0.879 (p=0.011) after EAT thickness inclusion.Conclusions. Male sex, level of triglycerides, HDL and hsCRP are statistically significant determinants of CA stenosis ≥70%. The presence of the triglycerides level in the created model underscores an important contribution of this lipid fraction, even when elevated only up to the moderate values, into modulation of the residual cardiovascular risk in patients receiving statins.https://www.rpcardio.online/jour/article/view/2108coronary atherosclerosistriglyceridesfibrateshigh density lipoprotein cholesterolepicardial adipose tissue thickness
spellingShingle O. A. Koshelskaya
T. E. Suslova
I. V. Kologrivova
N. Y. Margolis
O. A. Zhuravleva
O. A. Kharitonova
I. V. Vinnitskaya
Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
Рациональная фармакотерапия в кардиологии
coronary atherosclerosis
triglycerides
fibrates
high density lipoprotein cholesterol
epicardial adipose tissue thickness
title Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
title_full Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
title_fullStr Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
title_full_unstemmed Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
title_short Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
title_sort metabolic inflammatory and imaging biomarkers in evaluation of coronary arteries anatomical stenosis in patients with stable coronary artery disease
topic coronary atherosclerosis
triglycerides
fibrates
high density lipoprotein cholesterol
epicardial adipose tissue thickness
url https://www.rpcardio.online/jour/article/view/2108
work_keys_str_mv AT oakoshelskaya metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryarteriesanatomicalstenosisinpatientswithstablecoronaryarterydisease
AT tesuslova metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryarteriesanatomicalstenosisinpatientswithstablecoronaryarterydisease
AT ivkologrivova metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryarteriesanatomicalstenosisinpatientswithstablecoronaryarterydisease
AT nymargolis metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryarteriesanatomicalstenosisinpatientswithstablecoronaryarterydisease
AT oazhuravleva metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryarteriesanatomicalstenosisinpatientswithstablecoronaryarterydisease
AT oakharitonova metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryarteriesanatomicalstenosisinpatientswithstablecoronaryarterydisease
AT ivvinnitskaya metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryarteriesanatomicalstenosisinpatientswithstablecoronaryarterydisease